EHRA Premium Access

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal CON

Topic: Stroke Prevention in Cardioversion

Congress Presentation

11 more presentations in this session

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism- PRO

Speaker: Doctor S. Themistoclakis (Venice, IT)

Thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - CON

Speaker: Associate Professor T. Potpara (Belgrade, RS)

Thumbnail

Anticoagulation can be stopped after successful catheter ablation of AF in patients with CHADSVASC ≥2 risk of thromboembolism - Rebuttal PRO

Thumbnail

Chairperson conclusion & Closing question

Thumbnail

Access the full session

Tough decisions in anticoagulation in atrial fibrillation

Speakers: Doctor S. Themistoclakis, Associate Professor T. Potpara
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk